Search
SIFT-MS: Selected ion flow tube mass spectrometry
MALDI Biotyper from Bruker
High-throughput chemo-transcriptomics for drug discovery
Integrated acoustic dispensing and droplet microfluidics accelerate gene editing workflows
Cell and gene therapies pivotal for personalized medicine
Explore how the latest advancements and recent regulatory approvals are making truly personalized medicine a reality
Celloger Series: Automated live cell imaging system
Mastering food regulations and quality control
Real-time analysis in mining conveyor belt – CNA for mining
Cancer study emphasizes the need for non-targeted PFAS analysis
Non-targeted analysis (NTA) testing can help reveal the hidden dangers of 'forever chemicals’ following findings linking PFAS exposure to thyroid cancer
Integrated DNA Technologies and Element Biosciences, Inc. announce enhanced partnership
Companies unite in shared vision of enabling researchers to translate genomic insights
Series 340 prepASH TGA for thermogravimetric analysis
Cryogenic homogenization of food samples
SLAS2024 round-up
What next for CRISPR after first therapeutic approvals?
As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality
Corning launches the Elplasia 12K flask, for drug screening and other applications
Newest 3D cell culture solution from Corning enables production of ~12,000 spheroids of uniform size and geometry
Reducing liquid handling errors with INTEGRA Biosciences’ range of pipettes
INTEGRA’s range of ergonomic pipettes can help to maintain consistent pipetting angles
Ultrasensitive immunoassay technology drives blood-based biomarkers for Alzheimer's disease
Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials